Alpine Immune Sciences Inc (ALPN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2022 | 09-2022 | 06-2022 | 03-2022 | 12-2021 | |
| Sales | 2,776 | 8,367 | 5,292 | 13,629 | 4,530 |
| Gross Profit | 2,776 | 8,367 | 5,292 | 13,629 | 4,530 |
| Operating Expenses | 23,145 | 22,199 | 21,781 | 21,086 | 19,906 |
| Operating Income | -20,369 | -13,832 | -16,489 | -7,457 | -15,376 |
| Interest Expense | 87 | 105 | 130 | 154 | 178 |
| Other Income | 2,140 | 664 | 299 | 88 | 89 |
| Pre-tax Income | -18,316 | -13,273 | -16,320 | -7,523 | -15,465 |
| Income Tax | 548 | N/A | 1,778 | 4 | -298 |
| Net Income Continuous | -18,864 | -13,273 | -18,098 | -7,527 | -15,167 |
| Net Income | $-18,864 | $-13,273 | $-18,098 | $-7,527 | $-15,167 |
| EPS Basic Total Ops | -0.46 | -0.42 | -0.60 | -0.25 | -0.52 |
| EPS Basic Continuous Ops | -0.46 | -0.42 | -0.60 | -0.25 | -0.52 |
| EPS Diluted Total Ops | -0.46 | -0.42 | -0.60 | -0.25 | -0.52 |
| EPS Diluted Continuous Ops | -0.46 | -0.42 | -0.60 | -0.25 | -0.52 |
| EPS Diluted Before Non-Recurring Items | -0.41 | -0.42 | -0.60 | N/A | N/A |
| EBITDA(a) | $-21,558 | $-13,641 | $-16,074 | $-6,977 | $-14,934 |